Say NO to neurodegeneration: role of S-nitrosylation in neurodegenerative disorders
- PMID: 17901712
- DOI: 10.1159/000109071
Say NO to neurodegeneration: role of S-nitrosylation in neurodegenerative disorders
Abstract
Nitric oxide (NO) is an important signaling molecule that controls a wide range of biological processes. One of the signaling mechanisms of NO is through the S-nitrosylation of cysteine residues on proteins. S-nitrosylation is now regarded as an important redox signaling mechanism in the regulation of different cellular and physiological functions. However, deregulation of S-nitrosylation has also been linked to various human diseases such as neurodegenerative disorders. Nitrosative stress has long been considered as a major mediator in the development of neurodegeneration, but the molecular mechanism of how NO can contribute to neurodegeneration is not completely clear. Early studies suggested that nitration of proteins, which can induce protein aggregation might contribute to the neurodegenerative process. However, several recent studies suggest that S-nitrosylation of proteins that are important for neuronal survival contributes substantially in the development of various neurodegenerative disorders. Thus, in-depth understanding of the mechanism of neurodegeneration in relation to S-nitrosylation will be critical for the development of therapeutic treatment against these neurodegenerative diseases.
Copyright 2007 S. Karger AG, Basel.
Similar articles
-
Nitric oxide, S-nitrosylation and neurodegeneration.Cell Mol Biol (Noisy-le-grand). 2005 Sep 5;51(3):247-54. Cell Mol Biol (Noisy-le-grand). 2005. PMID: 16191392 Review.
-
Nitrosative stress in the ER: a new role for S-nitrosylation in neurodegenerative diseases.ACS Chem Biol. 2006 Jul 21;1(6):355-8. doi: 10.1021/cb600244c. ACS Chem Biol. 2006. PMID: 17163772 Review.
-
Modulation of pro-survival proteins by S-nitrosylation: implications for neurodegeneration.Apoptosis. 2010 Nov;15(11):1364-70. doi: 10.1007/s10495-010-0464-1. Apoptosis. 2010. PMID: 20131005 Review.
-
S-Nitrosylation and uncompetitive/fast off-rate (UFO) drug therapy in neurodegenerative disorders of protein misfolding.Cell Death Differ. 2007 Jul;14(7):1305-14. doi: 10.1038/sj.cdd.4402138. Epub 2007 Apr 13. Cell Death Differ. 2007. PMID: 17431424 Review.
-
S-nitrosylated protein-disulphide isomerase links protein misfolding to neurodegeneration.Nature. 2006 May 25;441(7092):513-7. doi: 10.1038/nature04782. Nature. 2006. PMID: 16724068
Cited by
-
Redox-based therapeutics in neurodegenerative disease.Br J Pharmacol. 2017 Jun;174(12):1750-1770. doi: 10.1111/bph.13551. Epub 2016 Aug 25. Br J Pharmacol. 2017. PMID: 27477685 Free PMC article. Review.
-
Nitrosative stress-induced Parkinsonian Lewy-like aggregates prevented through polyphenolic phytochemical analog intervention.Biochem Biophys Res Commun. 2011 Jan 7;404(1):324-9. doi: 10.1016/j.bbrc.2010.11.117. Epub 2010 Dec 3. Biochem Biophys Res Commun. 2011. PMID: 21130735 Free PMC article.
-
Glutathione: new roles in redox signaling for an old antioxidant.Front Pharmacol. 2014 Aug 26;5:196. doi: 10.3389/fphar.2014.00196. eCollection 2014. Front Pharmacol. 2014. PMID: 25206336 Free PMC article. Review.
-
S-nitrosylation of cyclin-dependent kinase 5 (cdk5) regulates its kinase activity and dendrite growth during neuronal development.J Neurosci. 2010 Oct 27;30(43):14366-70. doi: 10.1523/JNEUROSCI.3899-10.2010. J Neurosci. 2010. PMID: 20980593 Free PMC article.
-
Sildenafil Alleviates Murine Experimental Autoimmune Encephalomyelitis by Triggering Autophagy in the Spinal Cord.Front Immunol. 2021 May 13;12:671511. doi: 10.3389/fimmu.2021.671511. eCollection 2021. Front Immunol. 2021. PMID: 34054847 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical